Home About Amity Faculty Teaching Faculty

Faculty

Dr. Shweta Saraswat

Assistant Professor-I

Amity Institute Of Virology & Immunology

Viroids
Amity Institute of Virology and Immunology (AIVI)

Qualifications
PhD, 2016
Biological Science (Virology),
Bharathiar University, Coimbatore

M.Sc. Microbiology, 2008
First Division (67.75 %)
School of Science in Microbiology
Jiwaji University, Gwalior

B.Sc. Microbiology, 2006
First Division (72.28%)
Jiwaji University, Gwalior
• April 2022-till date: Assistant professor-I, Amity institute of Virology and Immunology, Amity University, NOIDA, U.P.
• 2017-2019: Conducting theory and practical classes of Industrial biotechnology at Shiv Nadar University.
• 2009-2010: Guest faculty at Jiwaji University, Gwalior, Conducting theory and practical classes of Industrial microbiology and virology.
Research associate-II: January 2021 to January 2022: RA-II in NII, Delhi on project "Comprehensive analysis of follicular helper T cells repertoire in flavivirus infection and vaccination".
Scientist: October 2019 to October 2020: Scientist in THSTI, Faridabad on project “Translational Research Consortium for establishing platform Technologies to support Prophylactic and Therapeutic strategies for Dengue- Discovery to proof-of-Concept
DST-NPDF: January 2017 to September 2019: National Post Doctoral Fellow, working in Shiv Nadar University, Greater Noida on project “Mapping of cleavage site of HEV ORF1 expressed using Baculovirus expression system
Industrial Biotechnology, Industrial Microbiology, Virology, Transplant Immunology, Translational Immunology, Target Organ and Diseases, Viral diseases in Human, Systematic virology II, Basics of Virology, Foundation of Immunology, Food Nutrition and Hygiene
• Assistant professor I: April 2022 to till date in Amity Institute of Virology and Immunology, Amity University, NOIDA, U.P.
• Research associate-II: January 2021 to January 2022: RA-II in NII, Delhi on project "Comprehensive analysis of follicular helper T cells repertoire in flavivirus infection and vaccination".
• Project Scientist: October 2019 to October 2020: Scientist in THSTI, Faridabad on project “Translational Research Consortium for establishing platform Technologies to support Prophylactic and Therapeutic strategies for Dengue- Discovery to proof-of-Concept.
• DST-NPDF: January 2017 to September 2019: National Post Doctoral Fellow, working at Shiv Nadar University, Greater Noida on the project “Mapping of the cleavage site of HEV ORF1 expressed using Baculovirus expression system.
• Doctoral Research Fellow: August 2010 to July 2016 in Virology Division Defence Research & Development Establishment, Gwalior, on project “Development of Chikungunya Virus like particles and their evaluation in disease diagnosis and prophylaxis.”
Panwar A, Kumar R, Goel R, Aggarwal S, Saraswat S, Bansal P, Gonmei Z, Toteja G, Yadav A, Lodha R, Singh N, Medigeshi G. Severe dengue in children associates with dysregulation of lipid homeostasis, complement cascade and retinol transport. Clin Transl Med. 2023 Jun;13(6):e1271. (IF 8.552)
2. Hooda P, Ishtikhar M, Saraswat S, Bhatia P, Mishra D, Trivedi A, Kulandaisamy R, Aggarwal S, Munde M, Ali N, AlAsmari AF, Rauf MA, Inampudi KK, Sehgal D. Biochemical and Biophysical Characterisation of the Hepatitis E Virus Guanine-7-Methyltransferase. Molecules. 2022 Feb 23;27(5):1505. (IF 4.5)
3. Shweta Saraswat, Meenakshi Chaudhary, and Deepak Sehgal. Hepatitis E Virus Cysteine Protease has Papain Like Properties Validated by in silico Modeling and Cell-Free Inhibition Assays. Front Cell Infect Microbiol. 2019; 9: 478. (IF 4.123)
4. Shweta Saraswat, Athmaram TN, Manmohan Parida, Ankita Agarwal, Amrita Saha, Paban Kumar Dash. Expression and characterization of yeast derived Chikungunya virus like particles (CHIK-VLPs) and its evaluation as a potential vaccine candidate. PLoS Negl Trop Dis. 2016;10:e0004782. (IF 3.948)
5. Shweta Saraswat, Athmaram Tn. A two step purification strategy for Chikungunya virions purification using sucrose buoyant density gradient separation. J Virol Res. 2013;2 :18-21. (IF 1.8)
6. Parida M, Dash PK, Kumar JS, Joshi G, Tandel K, Sharma S, Srivastava A, Agarwal A, Saha A, Saraswat S, Karothia D, Malviya V. Emergence of influenza A (H1N1) pdm09 Geno group 6B and drug resistant virus, India, January to May 2015. Euro Surveill. 2016;21(5):6-11. (IF 7.1)
7. Bhavna Sikarwar, Pushpendra K. Sharma, Shweta Saraswat, T. N. Athmaram, Mannan Boopathi, Beer Singh, Yogesh K. Jaiswal. Surface Plasmon Resonance Immunosensor for Recombinant H1N1 Protein. Plasmonics 2015;10:77-85 (IF 2.36)
8. T.N. Athmaram, Shweta Saraswat, Bhavna Sikarwar, Shailendra Kumar Verma, Anil K. Singh and M. Boopathi. Characterization of pandemic influenza A (H1N1) virus hemagglutinin specific polyclonal antibodies for biosensor applications. J Med. Virol. 2014;86:363-371 (IF 2.73)
9. T N Athmaram, Anil Kumar Singh, Shweta Saraswat, Saurabh Srivastava, Princi Misra, M Kameswara Rao, N Gopalan, P V L Rao. A simple Pichia pastoris fermentation and downstream processing strategy for making recombinant pandemic Swine Origin Influenza A virus Hemagglutinin protein. J Ind Microbiol Biotechnol 2013;40:245-255(IF 3.79)
10. T N Athmaram, Shweta Saraswat, Anil Kumar Singh, M Kameswara Rao, N Gopalan, V V S Suryanarayana, P V L Rao. Influence of copy number on the expression levels of pandemic influenza hemagglutinin recombinant protein in methylotrophic yeast Pichia pastoris. Virus Genes 2012; 8569 (IF 2.58)
11. T N Athmaram, Shweta Saraswat, Princi Misra, Saurabh Shrivastava, Anil K Singh, Shailendra K Verma, N Gopalan,Prativa K Behara, P V L Rao. Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications. Virus Genes 2012; 46(2) (IF 2.58)
12. TN Athmaram, Shweta Saraswat, SR Santhosh, Anil Kumar Singh,, VVS Suryanarayana, Raj Priya, N Gopalan, Manmohan Parida, PV Lakshmana Rao, and R Vijayaraghavan. Yeast expressed recombinant Hemagglutinin protein of Novel H1N1 elicits neutralising antibodies in rabbits and mice Virology Journal 2011; 8:524 (IF 3.35)
Amity Institute of Virology and Immunology (AIVI)